Is IVF Success Rate High at Age 40 in Hong Kong? Success Rate Data & Clinical Analysis

The success rate of IVF in Hong Kong for a 40-year-old woman depends on ovarian reserve, AMH level, and embryo chromosomal normality. Clinical data shows a live birth rate per single transfer of approximately 15%-25%, requiring a comprehensive evaluation based on individual test results.

Is IVF Success Rate High at Age 40 in Hong Kong? Success Rate Data & Clinical Analysis

Opening: Real Consultation Scenario

"Doctor, I am 40 years old this year. What is the actual success rate of doing IVF in Hong Kong?"

This is a frequently asked question in reproductive clinics. Patient Ms. Chen (pseudonym) sat in the consultation room, with her test reports from the past three months in front of her: AMH 0.8 ng/mL, FSH 12.5 IU/L, and a transvaginal ultrasound showing an antral follicle count of 3 to 4 on each side. She had tried to conceive naturally for a year without success and had also researched a lot of information about assisted reproduction in Hong Kong, but the more she read, the more confused she became—some said the success rate was very high, others said her chances were slim due to her age. She wanted to know, given her current physical condition, whether she still had a chance with IVF in Hong Kong and what the actual success rate would be.

This question is not simple. Answering it requires breaking it down from three dimensions: clinical data, individual indicators, and technical conditions.

IVF at Age 40 in Hong Kong: Success Rate Data Range

According to recent clinical statistics from several Hong Kong medical centers with assisted reproduction qualifications, for a 40-year-old woman using her own eggs for IVF, the live birth rate per single embryo transfer is approximately 15% to 25%. If considering the cumulative live birth rate (i.e., the probability of ultimately achieving a live birth from embryos obtained from the same egg retrieval cycle transferred in separate attempts), this figure can increase to around 30% to 40%.

It needs to be clear: these numbers are population-based statistical results and cannot be directly applied to an individual. The highly individualized nature of success rates means that the actual probability for each patient is different. Core variables include ovarian reserve, egg quality, sperm quality, embryo chromosomal normality, and the uterine environment.

Key Conclusion: For IVF at age 40 in Hong Kong using own eggs, the live birth rate per single transfer is about 15% to 25%, and the cumulative live birth rate is about 30% to 40%. However, this data is based on the premise that ovarian reserve is acceptable (AMH ≥ 0.8 ng/mL, antral follicle count ≥ 5) and that embryo culture and transfer techniques meet standard levels.

Why Age is a Key Variable Affecting Success Rate

The number of follicles in a woman's ovaries is fixed at birth, approximately 1 to 2 million. After puberty, follicles continuously undergo atresia and depletion. After age 35, the rate of follicle atresia accelerates significantly, and both the quantity and quality of follicles decline simultaneously. By age 40, ovarian reserve is usually at a low level, and more importantly, the rate of chromosomal aneuploidy in eggs increases exponentially with age.

  • At age 35: Egg chromosomal abnormality rate is about 30% to 40%
  • At age 40: Egg chromosomal abnormality rate is about 60% to 70%
  • At age 45: Egg chromosomal abnormality rate can reach 80% to 90%

Embryos with chromosomal abnormalities cannot develop into healthy fetuses or may result in early miscarriage after implantation. This is the fundamental biological reason for the decline in IVF success rates with advanced maternal age. Even though Hong Kong's embryo culture techniques and PGT-A screening capabilities are at an internationally advanced level, they cannot reverse the decline in egg quality caused by age. Assisted reproductive technology can optimize embryo selection but cannot create normal eggs.

Doctor's Perspective: Indicator System for Evaluating Success Rate in 40-Year-Old Patients

As a reproductive specialist, when evaluating the IVF success rate for a 40-year-old patient, the focus is not on the age number itself, but on the combination of the following four groups of indicators:

Evaluation Dimension Key Indicator Reference Range (Age 40) Impact on Success Rate
Ovarian Reserve AMH ≥ 1.0 ng/mL (better) Determines the basis for number of eggs retrieved
Ovarian Function Basal FSH < 10 IU/L (normal) Reflects the ovary's response to stimulation medication
Basal Follicle Count Antral Follicle Count (AFC) Bilateral ≥ 5 (better) Directly related to number of eggs retrieved
Sperm Quality Sperm DNA Fragmentation Index < 15% (normal) Affects embryo developmental potential
Embryo Chromosomes PGT-A Result Higher euploidy rate is better Determines efficiency per single transfer

If a 40-year-old patient has AMH > 1.0 ng/mL, FSH < 10 IU/L, antral follicle count > 5, and normal sperm parameters, her expected success rate would be closer to or even exceed the upper limit of the population statistics. Conversely, if AMH < 0.5 ng/mL, FSH > 15 IU/L, and antral follicle count is only 2 to 3, the number of eggs retrieved will be very limited, and the success rate will be significantly lower than average.

Comparison of Success Rates and Embryo Chromosomal Abnormality Rates Across Different Age Groups

The following table summarizes data based on multi-center clinical statistics to help understand the gradient of age's impact on IVF outcomes:

Age Group Live Birth Rate per Single Transfer (Own Eggs) Embryo Chromosomal Abnormality Rate Cumulative Live Birth Rate per Egg Retrieval Cycle
Under 35 40% – 50% 20% – 30% 55% – 65%
35 – 38 30% – 40% 30% – 40% 45% – 55%
38 – 40 20% – 30% 40% – 50% 35% – 45%
40 – 42 15% – 25% 60% – 70% 30% – 40%
42 – 44 5% – 10% 70% – 80% 10% – 20%
Over 44 < 5% 80% – 90% < 10%

From the table, it is clear that age 40 is a significant turning point—the embryo chromosomal abnormality rate exceeds 60%, and the live birth rate drops below 25%. This also explains why, after age 40, doctors place greater emphasis on the importance of PGT-A screening and cumulative embryo transfer strategies.

Interpretation of Key Diagnostic Indicators: How to Assess Your Own Probability of Success

Before deciding to undergo IVF in Hong Kong, it is recommended to complete the following core tests to obtain an individualized prediction of success rate:

Test Item Purpose of Test Reference Range for Age 40 Notes
AMH (Anti-Müllerian Hormone) Assess ovarian reserve ≥ 1.0 ng/mL (better) Not affected by menstrual cycle, can be tested anytime
Basal FSH + LH + E2 Assess ovarian function FSH < 10 IU/L Requires blood draw on day 2-4 of menstrual cycle
Transvaginal Ultrasound Antral Follicle Count Assess basal follicle number Bilateral total ≥ 5 Check on day 2-4 of menstrual cycle
Semen Analysis + DNA Fragmentation Index Assess sperm quality DNA Fragmentation Index < 15% Abstain for 2-7 days before testing
Thyroid Function (TSH) Assess endocrine environment TSH < 2.5 mIU/L Abnormalities can be adjusted with medication
Vitamin D Assess nutritional status ≥ 30 ng/mL Deficiency can be supplemented

Combined, these test results can relatively accurately predict the ovarian response to stimulation medication, the expected range of eggs retrieved, and the approximate probability of normal embryo chromosomes. Based on these data, the doctor can determine whether you belong to a group with a "better prognosis" or a "limited prognosis" and formulate a corresponding treatment strategy.

Easily Overlooked Details: Three Often Underestimated Factors

In clinical practice, I have found that patients around age 40, while focusing on age and AMH, often overlook the following three aspects, which can sometimes significantly affect the outcome:

1. Sperm Quality—Especially DNA Fragmentation Index

Sperm quality in a 40-year-old male can also decline significantly, particularly an increase in the sperm DNA fragmentation index. Sperm with a high DNA fragmentation index, even if morphology and motility are normal, may carry fragmented or damaged genetic material, leading to arrested embryo development, low blastocyst formation rate, or implantation failure after transfer. It is recommended that the male partner simultaneously undergo a semen DNA fragmentation index test, which is a routine examination item in Hong Kong's reproductive centers.

2. Vitamin D Levels and Thyroid Function

Vitamin D deficiency is associated with decreased ovarian function and lower embryo implantation rates. Thyroid dysfunction (especially subclinical hypothyroidism) can also affect follicle development and embryo implantation. These two tests are low-cost and highly manageable but are often missed. If abnormalities exist, they can usually be adjusted to the normal range within 1-2 months through oral medication or supplements.

3. Psychological Stress and Sleep Quality

Being under high stress for a long time can lead to elevated cortisol levels, which in turn inhibit the function of the hypothalamic-pituitary-ovarian axis, affecting follicle development and ovulation. A 40-year-old woman already faces greater fertility anxiety, and if work and family pressures are added, the endocrine environment may further deteriorate. Maintaining a relatively stable routine and emotional state during the IVF cycle is an easily underestimated but indeed important supportive factor.

Actual Process and Time Planning for IVF in Hong Kong

A complete IVF cycle, from initial consultation to pregnancy test, typically takes 2 to 3 months. For a 40-year-old patient, due to the potential need for PGT-A screening and frozen embryo transfer, it is advisable to allow a more flexible time window. The standard process is as follows:

Stage Main Content Estimated Time Need to Travel to Hong Kong?
① Initial Consultation & Assessment Complete fertility tests, doctor consultation, develop individualized plan 1 – 2 days Yes
② Ovarian Stimulation Daily injections of stimulation medication, monitoring follicle growth every 2-3 days 10 – 14 days Yes (can be done in Hong Kong or locally with remote guidance, but Hong Kong is recommended)
③ Egg Retrieval Surgery Transvaginal egg retrieval under anesthesia, surgery time about 15-20 minutes 1 day Yes
④ Embryo Culture + PGT-A Culture to blastocyst (5-6 days), biopsy and send for PGT-A 2 – 4 weeks (including PGT-A waiting time) No need to wait in Hong Kong, can receive results remotely
⑤ Frozen Embryo Transfer Endometrial preparation (hormone replacement or natural cycle), transfer 1 or 2 embryos 1 day (transfer day) Yes
⑥ Luteal Support & Pregnancy Test Use progesterone medication for support after transfer, blood test for HCG on day 14 14 days Can be done locally

For a 40-year-old patient, doctors usually recommend PGT-A screening (preimplantation genetic testing for aneuploidy) to select chromosomally normal embryos for transfer. This can significantly improve the efficiency of a single transfer but also adds approximately 2-4 weeks of time and additional costs (approximately HKD 20,000 – 40,000).

Time Suggestion: For a 40-year-old patient undergoing IVF in Hong Kong, it is recommended to reserve a total time span of 3-4 months, including preliminary tests, ovarian stimulation, egg retrieval, PGT-A waiting, transfer, and pregnancy test. If work schedule is tight, the PGT-A waiting period can be spent back on the mainland, returning to Hong Kong for the transfer once results are available.

Frequently Asked Questions

Q1: What tests are needed for IVF at age 40 in Hong Kong?
For the woman: AMH, basal FSH+LH+E2, transvaginal ultrasound antral follicle count, thyroid function (TSH), Vitamin D, infectious disease screening (Hepatitis B, Syphilis, HIV, etc.). For the man: Semen analysis, sperm DNA fragmentation index, infectious disease screening. It is recommended to have all test reports ready before the initial consultation. Hong Kong reproductive centers usually accept test results from top-tier hospitals in Mainland China, but some items may need to be re-checked in Hong Kong.
Q2: What is the approximate total cost for the entire cycle?
A standard cycle (excluding PGT-A) costs approximately HKD 100,000 – 150,000, including stimulation medication, egg retrieval surgery, embryo culture, and transfer costs. Adding PGT-A screening increases the cost by approximately HKD 20,000 – 40,000. Medication costs vary significantly due to individual response; some patients may require higher doses of stimulation medication, leading to higher costs.
Q3: How many times do I need to travel to Hong Kong, and how long is each stay?
Typically, 3-5 trips to Hong Kong are needed. First initial consultation: 1-2 days; Ovarian stimulation phase: about 10-14 days (recommended to stay in Hong Kong for the entire or most of this period); Egg retrieval surgery: 1 day; Transfer surgery: 1 day. If PGT-A screening is chosen, there is a 2-4 week period where you do not need to be in Hong Kong. Overall, it is advisable to plan your time well before each trip, especially during the stimulation phase which requires continuous monitoring.
Q4: My AMH is very low (< 0.5 ng/mL). Is it still worth going to Hong Kong?
Very low AMH indicates severely diminished ovarian reserve, and the number of eggs retrieved may be very limited (1-3). In this case, the success rate using your own eggs decreases significantly. However, a small number of patients may still obtain usable embryos through minimal stimulation or natural cycle protocols. It is recommended to complete a comprehensive evaluation first. If the doctor determines there is still a possibility of retrieving eggs, you can try one cycle; if the number of eggs retrieved remains consistently unsatisfactory, the possibility of an egg donation program should be discussed promptly.
Q5: What are the advantages of IVF technology in Hong Kong compared to Mainland China?
Hong Kong is relatively mature in embryo culture techniques (time-lapse imaging, blastocyst culture), the prevalence of PGT-A screening, and laboratory quality control. Additionally, medication options in Hong Kong are aligned with international standards, and stimulation protocols are highly individualized. However, it must be clear: technological advantages can optimize embryo selection and transfer efficiency, but cannot reverse the decline in egg quality caused by age. For a 40-year-old patient, technology can offer "selecting the most likely normal embryo from a limited pool," not creating more normal embryos.
Risk Reminder: For women over 40 undergoing IVF, the risks of pregnancy complications need to be known in advance. Clinical data shows that the rates of miscarriage (approximately 25% – 35%), gestational hypertension, and gestational diabetes in advanced maternal age pregnancies are significantly higher than in younger populations. After a successful pregnancy, prenatal diagnosis (such as amniocentesis or chorionic villus sampling) is an important recommended test. Furthermore, if after 1-2 egg retrieval cycles, the number of eggs retrieved remains consistently unsatisfactory (≤ 3) or the embryo chromosomal abnormality rate is too high (euploidy rate below 20%), it is recommended to thoroughly discuss egg donation programs or other family-building paths with your doctor to avoid unnecessary financial and emotional strain from persistent attempts. Every couple's situation is unique, and decisions should be based on a complete medical evaluation and personal values.

— This article is compiled based on clinical consensus in assisted reproduction and publicly available data from multiple centers, and does not serve as a commitment for individual treatment. Please refer to the in-person evaluation at a reproductive center for specific plans.

0 comments
Leave a Reply